ロード中...
Current paradigms and Evolving concepts in metastatic castration-resistant prostate cancer
Until recently, docetaxel-based therapy represented the only therapy shown to prolong survival in patients with metastatic castration-resistant prostate cancer (mCRPC). The past year and a half has been marked by unprecedented progress in treatments for this disease. Three positive phase III clinica...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3449061/ https://ncbi.nlm.nih.gov/pubmed/21602834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/aja.2011.35 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|